Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Non-Current Debt: 2016

Historic Non-Current Debt for Niagen Bioscience (NAGE) over the last 1 years, with Jan 2016 value amounting to $3.3 million.

  • Niagen Bioscience's Non-Current Debt was N/A to $3.3 million in Q1 2016 from the same period last year, while for Jan 2016 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $3.3 million for FY2016, which is N/A change from last year.
  • According to the latest figures from FY2016, Niagen Bioscience's Non-Current Debt is $3.3 million.
  • In the past 5 years, Niagen Bioscience's Non-Current Debt ranged from a high of $3.3 million in FY2016 and a low of $3.3 million during FY2016.
  • In the last 1 years, Niagen Bioscience's Non-Current Debt had a median value of $3.3 million in 2016 and averaged $3.3 million.